{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:33Z","timestamp":1786998453007,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1A2A2A04004455"],"award-info":[{"award-number":["2015R1A2A2A04004455"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.yexmp.2017.02.015","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T19:48:01Z","timestamp":1488224881000},"page":"321-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparison of FFPE histological versus LBP cytological samples for HPV detection and typing in cervical cancer"],"prefix":"10.1016","volume":"102","author":[{"given":"Geehyuk","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemi","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-young","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunghyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Hwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yexmp.2017.02.015_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119755","article-title":"HERMES study group. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology","volume":"10","author":"Agorastos","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.yexmp.2017.02.015_bb0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bpobgyn.2011.05.003","article-title":"Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines","volume":"25","author":"Almonte","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"11","key":"10.1016\/j.yexmp.2017.02.015_bb0015","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer","volume":"87","author":"Bosch","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.yexmp.2017.02.015_bb0020","first-page":"1369","volume":"61","author":"Canavan","year":"2000","journal-title":"Am. Fam. Physician"},{"issue":"Suppl 10","key":"10.1016\/j.yexmp.2017.02.015_bb0025","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"J Vaccine."},{"issue":"7","key":"10.1016\/j.yexmp.2017.02.015_bb0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjos\u00e9","year":"2007","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.yexmp.2017.02.015_bb0030","first-page":"219","article-title":"Human papilloma virus DNA in cervical samples with cytological abnormalities and typing of the virus","volume":"41","author":"Erg\u00fcnay","year":"2007","journal-title":"Mikrobiyol. Bul."},{"issue":"4","key":"10.1016\/j.yexmp.2017.02.015_bb0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4132\/KoreanJPathol.2009.43.4.342","article-title":"Prevalence and genotype distribution of cervical human papillomavirus DNA in Korean women: a multicenter study","volume":"43","author":"Hong","year":"2009","journal-title":"Korean J. Pathol."},{"issue":"2","key":"10.1016\/j.yexmp.2017.02.015_bb0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AOG.0000000000000669","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"125","author":"Huh","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.yexmp.2017.02.015_bb0045","series-title":"IARC Handbooks of Cancer Prevention, 2004","volume":"Vol. 9","author":"International Agency for Research on Cancer World Health Organization (WTO)","year":"2004"},{"issue":"11","key":"10.1016\/j.yexmp.2017.02.015_bb0050","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1158\/1055-9965.EPI-12-0663","article-title":"Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection","volume":"21","author":"Jensen","year":"2012","journal-title":"Cancer Epidemiol. Biomarl. Prev."},{"issue":"8","key":"10.1016\/j.yexmp.2017.02.015_bb0055","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/jmv.23334","article-title":"REBA HPV-ID\u00ae for efficient genotyping of human papillomavirus in clinical samples from Korean patients","volume":"84","author":"Kim","year":"2012","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.yexmp.2017.02.015_bb0060","first-page":"123","article-title":"Clinical evaluation of human papillomavirus DNA genotyping assay to diagnose women cervical cancer","volume":"18","author":"Kim","year":"2012","journal-title":"J. Exp. Biomed Sci."},{"issue":"2","key":"10.1016\/j.yexmp.2017.02.015_bb0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2012.11.003","article-title":"The role of co-factors in the progression from human papillomavirus infection to cervical cancer","volume":"128","author":"Luhn","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexmp.2017.02.015_bb0070","series-title":"Cancer Incidence in Five Continents","first-page":"155","volume":"vol. 8","author":"Parkin","year":"2002"},{"issue":"8","key":"10.1016\/j.yexmp.2017.02.015_bb0080","doi-asserted-by":"crossref","first-page":"930","DOI":"10.5858\/2003-127-930-HPEAPH","article-title":"Human papillomavirus: epidemiology and public health","volume":"127","author":"Schiffman","year":"2003","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"9","key":"10.1016\/j.yexmp.2017.02.015_bb0085","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1128\/JVI.80.9.4249-4263.2006","article-title":"The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation","volume":"80","author":"Tang","year":"2006","journal-title":"J. Med. Virol."},{"issue":"Suppl 1","key":"10.1016\/j.yexmp.2017.02.015_bb0090","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Virol."},{"issue":"687\u201397","key":"10.1016\/j.yexmp.2017.02.015_bb0095","first-page":"W214","article-title":"Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force","volume":"155","author":"Whitlock","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.yexmp.2017.02.015_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480016302180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480016302180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T18:16:00Z","timestamp":1658686560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480016302180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0014480016302180"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.02.015","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of FFPE histological versus LBP cytological samples for HPV detection and typing in cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}